opinion 海外バイオ企業のA社 売上は単品で米国のみで200億円程度。今後伸びてゆく見込。日本へは進出していないが、日本でのライセンスパートナーを求めていた。比較的小さな適応であるが、今後適応拡大が期待出来た。日本でのパートナーを一生懸命探した結果、漸く一社からオファーを...... 12.26.2020 opinion
publication Jetro Lecture in Toronto Mr. Ozaki was invited to a lecture sponsored by JETRO in 2006. He spoke about the role of VC and the bio investment envi...... 12.06.2020 publication
publication Clinical Trials in Ontario Mr. Ozaki’s primary roles of his tenure as CEO of Canadian Affiliate was to maintain and enhance its partnership with ke...... 12.06.2020 publication
publication Astellas Pharma Canada Interview Mr. Ozaki was featured by one of journals specialized in Pharma business, Canadian Pharmaceutical Marketing in 2005CPMCP...... 12.06.2020 publication
publication Article on Canada Business Mr. Ozaki operated a Canadian subsidiary of one of major Japanese pharmaceutical companies as CEO for 6 years. This arti...... 12.06.2020 publication
publication Lecture on JV Management Earlier on his career, Mr. Ozaki spent 9 years from 1981 through 1990 in management of a JV located in Philadelphia. The...... 12.06.2020 publication
message Philosophy of SPC Mission日本における医薬品イノベーションを起こす。その為に働くCarry out whatever advisory roles to inspire Bio and Pharma Innovation in JapanVision3...... 12.05.2020 message